Atopic dermatitis (AD) is associated with imunoregulatory abnormalities similar to those observed in acute Kawasaki Syndrome (KS) as well as with increased susceptibility to viral infections. We investigated whether the prevalence of AD is increased among children who acquire KS. In a case-control telephone survey, 83 KS patients and 83 controls with innocent heart murmur were matched for age and time period between clinic visit and interview. The nurse-interviewer was blinded to the study's hypothesis. Cases and controls were similar in socioeconomic status, racial distribution, and number of winters in New England. Atopic dermatitis was defined as a chronic eczematoid dermatitis (separate from rash of KS) associated with personal or family history of inhalant allergy. Nine (11%) KS patients but only 1 (1%) control patient had AD; the odds of AD was 9 times greater in KS than in control patients (p 1.01, Mantel-Haenszel). Serum IgE levels were srgnificantly higher (p <.02, Mann-Whitney) in 44 unselected KS patients (median 22, range (4 to 900 IU/ml) studied 6 to 12 months after onset than in 27 controls (median (4, range (4 to 164 IU/ml). We conclude that children who acquire KS are significantly more likely than matched controls to have atopic dermatitis. (Nature 323:814, 1986). To further define its template specificity and persistence after clinical recovery and gammaglobulin (GG) therapy, we studied 89 cxs from 33 KD pts and 33 controls. Of the KD pts 23/33 (70%) showed RTA above the mean + 2 SD for control pts (5.6 picomoles dTMP incorporated). The mean peak RTA for KD PBMC cx supernatants was 8.2 pmoles t 1.8 vs. 3.7 pmoles t 0.5 for the controls ( p ( .05). GG therapy did not prevent expression of RTA which was detected 3-8 weeks post-treatment in cxs from 416 KD pts. RTA was detected in PBMC from pts as late as 9 years following acute KD. Co-cultivation of PBMC or cell-free supernatants from PBMC cxs with the HUT-78 cell line yielded RTA>control mean +2 SD (3.1 pmoles) in 14/18 (78%) attempts. Analysis of template/ primer specificity showed no increase in dTMP incorporation when assay conditions were altered to favor DNA pol I or terminal transferase. Duplicate assays to compare po1yrA:oligodT vs. po1yrC:oligodG showed comparable activity for the KD cxs. We conclude that the polymerase activity associated with the particulate fraction of supernatants from KD PBMC is consistent with RTA and can be detected late after recovery which suggests a retrovirus as the causative agent of KD. WC3 rotavirus vaccine or a placebo preparation was administered to 104 infants aged 3-12 months from Sept. 1985 to Jan. 1986 in a suburban Phila. middle class population. Infants were given a single dose of WC3 vaccine (107.3 pfu) or placebo and were monitored daily for one week for vaccine sequelae. Active surveillance for rotavirus diarrhea was performed until June. 1986. Sequelae observed during 7 days post vaccination for vaccine (V) and placebo (PI groups were: loose stools: 1 Z V . 9%P; vomiting: 10%V. 6%P; fever (~100.6~): 16%V. 11%P; irritability: 41%V. 44%P; the observed differences were not statistically significant. Rotavirus-associated diarrhea occurred between Jan. and May. 1986 in 14/55 placebo recipients and 3/49 vaccinees (protection rate = 76%. p = t0.02). Clinical scoring of gastroenteritis (GE) revealed an incidence of moderate to severe rotavirus disease of 11/55 in (P) recipients and 0/49 in (V) (protection = 100%. p = <0.001). A rotavirus strain that was isolated and identified as serotype 1 was associated with 14/17 cases of rotavirus diarrhea. Preliminary serological data suggests that serotype 1 or serotype 3 rotavirus infection also occurred in approximately 20% of infants in whom rotavirus GE was not detected, in both vaccine and placebo groups. The results suggest that WC3 vaccine protects against severe rotavirus disease and may also protect against rotavirus infection. for the presence and characteristics of C. trachomatis antibody in HBM, S and CS. Antibody to s. trachomatis was detected by a direct ELISA method using partially purified elementary bodies of strain LGV-2 as antigen. Antibody specificity was confirmed using the appropriate absorption and blocking controls. Evidence of infection was indicated by a positive culture or presence of specific antigen. In an unprecedented finding, chlamydia1 antibody, primarily secretory IgA (SIgA), was detected in HBM in 7 of 33 normal women. SIgA was detected with a geometric mean titer (GMT) of 28.8. The other antibody isotypes were the following: IgG 4.79, IgM 2.4, and IgA 9.7. Serum IgG GMT in patients with recent infection were 128.821.8 in comparison to those with no recent infection at 6.328.9. Serum IgM was present, GMT 6.823.7, in patients with infection in contrast to those with no infection. In CS of patients with recent infection, IgG (7.925.4) and SIgA (15.92 1.8) were present, and surprisingly in patients having no evidence of recent infection there was a persistence of SIgA at a titer of 8. The immune response to varicella-zoster virus (VZV) includes antibody (Ab) to virally-specified proteins (P) and glycoproteins (GP). W e analyzed A b after chickenpox (CP), zoster (Z), and live attenuated varicella vaccine (LAVV) by western blot (WB). Responses to 2 of the 3 major GPs were identified by comparing bands on standard W B s using infected VZV cell lysate as antigen with a reference W B in which Z serum was reacted with purified GP I and GP 11. A mouse monoclonal A b to GP I confirmed its location, and all 3 GPs were visualized on silver stain of SDS-polyacrylamide gel. Preimmune sera and an uninfected cell lysate were controls. All convalescent sera from patients with CP(N=5) had antibody t o GP I (bands at 99 and 92 kilodaltons [kd]), GP I1 (125 kd), and GP III (1 13 kd). In addition 515 had a strong band at 147 kd and 415 had a band at 39 kd, near the molcc. wt. of VZV deoxypyrimidine kinase. Bands were well-preserved to GP 1 in 5 remote CP sera, but faint at GP I1 and I11 and at 147 kd. In 718 pis. post Z , bands at all 3 G P s and at 39 kd were darker than after recent CP despite equivalent fluorescent antibody to membrane antigen (FAMA) titers. Z sera also had bands at 51,48,46, and 43 which were absent or faint post CP. After 2 doses of L A V V , 1011 1 vaccinees had bands at GP I. Fewer (611 1) had a band at GP I1 and only 311 1 had a band at GP 111. However,the W B s of 4 vaccinees after breakthrough CP were similar in intensity and band location to WBs post Z. Ten leukemic children w h o lost FAMA A b after LAVV and later reseroconverted without clinical illness also had W B s resembling the anamnestic profile seen post Z. Even when FAMA negative, these silent FAMA reconverters were protected from serious CP. W B is useful in distinguishing secondary from primary immune response to VZV.
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